Plandai Biotechnology Inc Takes A Hit

After reporting a green session on Tuesday, the stock price of Plandai Biotechnology Inc (OTCMKTS:PLPL) is once again moving south on the chart. Yesterday, the stock declined more than 3% to close the trading session at $0.125. The company recently confirmed the news of a extended deal with USN following which it will supply Phytofare® catechin complex to the respective company and its associates.

The VP of Sales and Marketing for Plandai said that USN acknowledges the many benefits of phyto-availability™. In fact the group is keen to use the Phytofare component in their absolute best quality products sold to clients. Phytofare® is believed to be a magical component that supplies active ingredients to the blood stream.

The VP added that they are delighted with the extensive use of Phytofare by USN in its products meant for various target markets including South Africa, Europe and Australian continent. This deal extension is encouraging...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.journaltranscript.com/2015/09/plandai-biotechnology-inc-otcmktsplpl-takes-a-hit/